Skip to menu Skip to content Skip to footer
Professor Sandro Porceddu
Professor

Sandro Porceddu

Email: 

Overview

Background

Profile Summary

Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is currently a senior radiation oncologist and Director of radiation oncology research at the Princess Alexandra Hospital, Brisbane, Professor of Medicine, University of Queensland and Associate Editor for the International Head and Neck journal, Oral Oncology.

Dr Porceddu is a nationally and internationally recognised cancer advocate through his involvement in high-level committees, engagement with key policymakers, community education and media roles.

Career Summary

Professor Porceddu completed his medical degree at Monash University before undertaking his residency at Monash Medical Centre, Melbourne. He commenced his specialist training in radiation oncology at the Peter MacCallum Cancer Centre in 1996 and was made Fellow of the Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology in 2000. After working as a consultant radiation oncologist at PeterMac for several years he moved to the Princess Alexandra Hospital in 2004.

Professional Committees and Organisations

Professor Porceddu has been the President of the Clinical Oncology Society of Australia (COSA), the peak organisation for cancer-related health professionals, and the Trans Tasman Radiation Oncology Group (TROG), one of the largest cancer collaborative trials group in Australia/New Zealand. He has served on numerous national and international professional and academic committees including the board of the Cancer Council of Australia, the National Cancer Expert Reference Group for the Commonwealth and the International Union for the Control of Cancer (UICC) TNM Expert Advisory Panel.

Currently, he is the Chair of the Cancer Council Queensland Co-operative Oncology Group, a committee that provides over $1.2M per annum to support clinical research throughout Queensland and is on the board of the of the Head and Neck Cancer InterGroup (HNCIG), a group of leading world cancer experts dedicated to promoting the global harmonisation of head and neck cancer research and treatment.

Academic Highlights

Professor Porceddu runs an active clinical research program with over 150 peer-review articles, book chapters, published abstracts, invited reviews and commentaries. He has received invitations to speak at major international conferences such as the American Society of Clinical Oncology (ASCO) meeting and publish in prestigious journals such as the Lancet Oncology and Journal of Clinical Oncology.

Awards

Trans Tasman Radiation Oncology Group Outstanding Contribution

American Head and Neck Society Chris O’Brien Travelling Scholar

Pre-eminent status by Queensland Health

Rouse Fellowship, Royal Australian and New Zealand College of Radiologists

Teaching

Dr Porceddu has had a life-long commitment to teaching and is a supervisor and mentor to Doctor of Philosophy and Master of Philosophy candidates, Clinical Research Fellows, MBBS Honours students, resident, registrars and other allied health professionals.

Availability

Professor Sandro Porceddu is:
Available for supervision

Qualifications

  • Bachelor of Science, Monash University
  • Bachelor of Medicine and Surgery and Medical Science, Monash University
  • Doctoral Diploma of Medicine, The University of Queensland

Research impacts

Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised Phase III trial on head and neck skin cancer (POST TROG 05.01). In line with his research goals he has been examining the integration of radiation therapy and new technologies in the management of head and neck cancer and has received his Doctorate of Medicine (MD) on this topic with UQ. His current research on Positron Emission Tomography in the management of the neck following chemo-radiotherapy has been internationally recognised and incorporated into the USA National Comprehensive Cancer Network (NCCN) guidelines. He has been the recipient of over $3.91M in competitive funding, including one recently closed and two open NHMRC grants.

Works

Search Professor Sandro Porceddu’s works on UQ eSpace

176 works between 1999 and 2025

81 - 100 of 176 works

2016

Journal Article

The role of postoperative radiotherapy for large nerve perineural spread of cancer of the head and neck

Gorayski, Peter, Foote, Matthew, Porceddu, Sandro and Poulsen, Michael (2016). The role of postoperative radiotherapy for large nerve perineural spread of cancer of the head and neck. Journal of Neurological Surgery, Part B: Skull Base, 77 (2), 173-181. doi: 10.1055/s-0036-1571839

The role of postoperative radiotherapy for large nerve perineural spread of cancer of the head and neck

2016

Conference Publication

The use of predictive modeling in adaptive radiation therapy for head and neck cancer

Brown, E., Owen, R., Harden, F., Mengersen, K., Oestreich, K., Houghton, W., Poulsen, M. G., Harris, S., Lin, C. and Porceddu, S. (2016). The use of predictive modeling in adaptive radiation therapy for head and neck cancer. Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, United States, Feb 18-20, 2016. Philadelphia, United States: Elsevier. doi: 10.1016/j.ijrobp.2015.12.069

The use of predictive modeling in adaptive radiation therapy for head and neck cancer

2016

Conference Publication

The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (Ophnscc)

Peters, G., McGrath, M., Porceddu, S. and Coward, J. (2016). The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (Ophnscc). Implementation + Innovation in Immunotherapy, Surfers Paradise, Queensland, Australia, 3-5 August, 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12540

The influence of cisplatin de-escalation on survival outcomes in oropharyngeal head and neck squamous cell carcinoma (Ophnscc)

2016

Journal Article

Measuring head and neck lymphedema: the "ALOHA" trial

Purcell, Amanda, Nixon, Jodie, Fleming, Jennifer, McCann, Andrew and Porceddu, Sandro (2016). Measuring head and neck lymphedema: the "ALOHA" trial. Head and Neck, 38 (1), 79-84. doi: 10.1002/hed.23853

Measuring head and neck lymphedema: the "ALOHA" trial

2016

Journal Article

Head and neck adaptive radiotherapy: predicting the time to replan

Brown, Elizabeth, Owen, Rebecca, Harden, Fiona, Mengersen, Kerrie, Oestreich, Kimberley, Houghton, Whitney, Poulsen, Michael, Harris, Selina, Lin, Charles and Porceddu, Sandro (2016). Head and neck adaptive radiotherapy: predicting the time to replan. Asia-Pacific Journal of Clinical Oncology, 12 (4), 460-467. doi: 10.1111/ajco.12516

Head and neck adaptive radiotherapy: predicting the time to replan

2015

Journal Article

Examining user perceptions of SwallowIT: A pilot study of a new telepractice application for delivering intensive swallowing therapy to head and neck cancer patients

Wall, Laurelie R., Ward, Elizabeth C., Cartmill, Bena, Hill, Anne J. and Porceddu, Sandro V. (2015). Examining user perceptions of SwallowIT: A pilot study of a new telepractice application for delivering intensive swallowing therapy to head and neck cancer patients. Journal of Telemedicine and Telecare, 23 (1), 53-59. doi: 10.1177/1357633X15617887

Examining user perceptions of SwallowIT: A pilot study of a new telepractice application for delivering intensive swallowing therapy to head and neck cancer patients

2015

Journal Article

Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: Current concepts, advances, and controversies

Porceddu, Sandro V., Veness, Michael J. and Guminski, Alexander (2015). Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: Current concepts, advances, and controversies. Journal of Clinical Oncology, 33 (29), 3338-3345. doi: 10.1200/JCO.2014.60.7333

Nonmelanoma cutaneous head and neck cancer and merkel cell carcinoma: Current concepts, advances, and controversies

2015

Journal Article

Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy

Wall, Laurelie R., Cartmill, Bena, Ward, Elizabeth C., Hill, Anne J., Isenring, Elizabeth and Porceddu, Sandro V. (2015). Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy. Supportive Care in Cancer, 24 (3), 1227-1234. doi: 10.1007/s00520-015-2912-5

Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy

2015

Journal Article

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines

Brouwer, Charlotte L, Steenbakkers, Roel J.H.M, Bourhis, Jean, Budach, Wilfried, Grau, Cai, Gregoire, Vincent, van Herk, Marcel, Lee, Anne, Maingon, Philippe, Nutting, Chris, O'Sullivan, Brian, Porceddu, Sandro V, Rosenthal, David I, Sijtsema, Nanna M and Langendijk, Johannes A (2015). CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy and Oncology, 117 (1), 83-90. doi: 10.1016/j.radonc.2015.07.041

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines

2015

Journal Article

Predicting the need for adaptive radiotherapy in head and neck cancer

Brown, Elizabeth, Owen, Rebecca, Harden, Fiona, Mengersen, Kerrie, Oestreich, Kimberley, Houghton, Whitney, Poulsen, Michael, Harris, Selina, Lin, Charles and Porceddu, Sandro (2015). Predicting the need for adaptive radiotherapy in head and neck cancer. Radiotherapy and Oncology, 116 (1) 6509, 57-63. doi: 10.1016/j.radonc.2015.06.025

Predicting the need for adaptive radiotherapy in head and neck cancer

2015

Journal Article

Third-party disability in carers of people with dysphagia following non-surgical management for head and neck cancer

Nund, Rebecca L., Scarinci, Nerina A., Cartmill, Bena, Ward, Elizabeth C., Kuipers, Pim and Porceddu, Sandro V. (2015). Third-party disability in carers of people with dysphagia following non-surgical management for head and neck cancer. Disability and Rehabilitation, 38 (5), 462-471. doi: 10.3109/09638288.2015.1046563

Third-party disability in carers of people with dysphagia following non-surgical management for head and neck cancer

2015

Journal Article

Outcomes following surgery and post-operative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma

Warren, Timothy A., Panizza, Benedict, Porceddu, Sandro V., Gandhi, Mitesh, Patel, Parag, Wood, Martin, Nagle, Christina M. and Redmond, Michael (2015). Outcomes following surgery and post-operative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head and Neck, 38 (6), 824-831. doi: 10.1002/hed.23982

Outcomes following surgery and post-operative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma

2015

Journal Article

Human papillomavirus status and p16INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia

Antonsson, Annika, Neale, Rachel E., Boros, Samuel, Lampe, Guy, Coman, William B., Pryor, David I., Porceddu, Sandro V. and Whiteman, David C. (2015). Human papillomavirus status and p16INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiology, 39 (2), 174-181. doi: 10.1016/j.canep.2015.01.010

Human papillomavirus status and p16INK4A expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia

2015

Journal Article

Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers

Nund, Rebecca L., Rumbach, Anna F., Debattista, Bridget C., Goodrow, Martha N. T., Johnson, Kori A., Tupling, Laura N., Scarinci, Nerina A., Cartmill, Bena, Ward, Elizabeth C. and Porceddu, Sandro V. (2015). Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers. International Journal of Speech-Language Pathology, 17 (3), 263-272. doi: 10.3109/17549507.2015.1010581

Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers

2015

Journal Article

Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy

Sjovall, Johanna, Chua, Benjamin, Pryor, David, Burmeister, Elizabeth, Foote, Matthew C., Panizza, Benedict, Burmeister, Bryan H. and Porceddu, Sandro V. (2015). Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy. Oral Oncology, 51 (3), 260-266. doi: 10.1016/j.oraloncology.2014.12.009

Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy

2015

Journal Article

Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists

Lewis, Stephen L., Porceddu, Sandro, Nakamura, Naoki, Palma, David A., Lo, Simon S., Hoskin, Peter, Moghanaki, Drew, Chmura, Steven J. and Salama, Joseph K. (2015). Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists. American Journal of Clinical Oncology: Cancer Clinical Trials, 40 (4), 418-422. doi: 10.1097/COC.0000000000000169

Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists

2015

Book Chapter

Skin: basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma

Porceddu, Sandro V., Veness, Michael J. and Soyer, H. Peter (2015). Skin: basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma. UICC manual of clinical oncology. (pp. 674-688) edited by Brian O'Sullivan, James D. Brierley, Anil K. D'Cruz, Martin F. Fey, Raphael Pollock, Jan B. Vermorken and Shao Hui Huang. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/9781119013143.ch53

Skin: basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma

2015

Conference Publication

Innovating Multidisciplinary Triage of Head and Neck Cancer Patients and Their Carers During (Chemo)Radiotherapy: the "screenit" System

Wall, Laurelie, Cartmill, Bena, Ward, Liz, Hill, Anne, Isenring, Elizabeth, Byrne, Joshua, Chambers, Suzanne, Dunn, Jeff, Nixon, Jodie, Whelan, Jane and Porceddu, Sandro (2015). Innovating Multidisciplinary Triage of Head and Neck Cancer Patients and Their Carers During (Chemo)Radiotherapy: the "screenit" System. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart TAS, Australia, 17–19 November 2015. Hoboken, NJ United States: Wiley-Blackwell.

Innovating Multidisciplinary Triage of Head and Neck Cancer Patients and Their Carers During (Chemo)Radiotherapy: the "screenit" System

2015

Conference Publication

Using technology to deliver prophylactic swallowing therapy for HNC patients: Analysis of consumer perceptions

Wall, L., Ward, E., Cartmill, B., Hill, A., Isenring, E., Byrnes, J. and Porceddu, S. (2015). Using technology to deliver prophylactic swallowing therapy for HNC patients: Analysis of consumer perceptions. Dysphagia Research Society 2015 Annual Meeting and Post-Graduate Course, Chicago, Illinois, USA, 11-14 March 2015. New York, NY United States: Springer.

Using technology to deliver prophylactic swallowing therapy for HNC patients: Analysis of consumer perceptions

2015

Book Chapter

Future directions in the management of non-melanoma skin cancer

Adams, Gerard and Porceddu, Sandro V. (2015). Future directions in the management of non-melanoma skin cancer. Non-Melanoma Skin Cancer of the Head and Neck. (pp. 193-201) edited by Riffat, F, Palme, CE and Veness, M. New Dehli, India: Springer India. doi: 10.1007/978-81-322-2497-6_13

Future directions in the management of non-melanoma skin cancer

Funding

Past funding

  • 2019 - 2020
    Head and neck lymphoedema treatment: An examination and development of current standards of care
    PA Research Foundation
    Open grant
  • 2013 - 2016
    Can a computerised home therapy program provide an effective and cost-efficient model for delivering intensive swallowing therapy? An RTC of an innovative service model...
    Princess Alexandra Hospital
    Open grant
  • 2013 - 2015
    The role of epidermal growth factor receptor trafficking in tumor progression and patient therapy resistance
    Cancer Council Queensland
    Open grant
  • 2007 - 2011
    Post-operative concurrent chemo-radiotherapy versus post-operative radiotheray in high-risk cutaneous squamous cell carcinoma of the head and neck
    Queensland Health Smart Health Research Grant
    Open grant

Supervision

Availability

Professor Sandro Porceddu is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Sandro Porceddu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au